Director/PDMR Shareholding
Updated : 11:51
24 January 2020
LXi REIT PLC
(the "Company")
(LEI: 2138008YZGXOKAXQVI45)
DIRECTOR/PDMR SHAREHOLDING
LXi REIT plc (ticker: LXI), the specialist inflation-protected very long income REIT, announces in accordance with LR 9.6.17R that it, together with Peel Hunt LLP, has granted a waiver to the lock-up arrangements entered into with John Cartwright, a director of the Company, in connection with ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") acquired by him in satisfaction of his entitlement to receive directors' fees and has consented to the sale by John Cartwright of 42,814 Ordinary Shares to Calvi Capital Limited, a private limited company owned by John Cartwright and his spouse.
Following the above transaction, John Cartwright's total shareholding, together with those persons closely associated with him, remains unchanged and is 66,687 Ordinary Shares.
Enquiries:
Maria Matheou |
|
PraxisIFM Fund Services (UK) Limited | 020 7653 9690 |
Company Secretary |
|
|
|
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation (No. 596/2014).
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||||
a)
| Name
| John Cartwright | ||||||
2
| Reason for the notification
| |||||||
a)
| Position/status
| Director | ||||||
b)
| Initial notification /Amendment
| Initial notification | ||||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||||
a)
| Name
| LXi REIT plc | ||||||
b)
| LEI
|
2138008YZGXOKAXQVI45 | ||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares 1 pence each | ||||||
|
|
| ||||||
Identification code |
| |||||||
|
| |||||||
b)
| Nature of the transaction
| Sale | ||||||
c)
| Price(s) and volume(s) |
|
|
|
| |||
|
|
| Price(s) | Volume(s) |
| |||
|
| 134.2p per share | 42,814 |
| ||||
|
|
|
|
| ||||
d)
| Aggregated information |
| ||||||
|
|
| ||||||
- Aggregated volume | 42,814 | |||||||
|
| |||||||
- Price | Total price £5,745,638.8 | |||||||
|
| |||||||
e)
| Date of the transaction
| 23 January 2020 | ||||||
f)
| Place of the transaction
| Outside of trading venue | ||||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||||
a)
| Name
| Calvi Capital Limited | ||||||
2
| Reason for the notification
| |||||||
a)
| Position/status
| Person closely associated with John Cartwright, a person discharging managerial responsibilities | ||||||
b)
| Initial notification /Amendment
| Initial notification | ||||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||||
a)
| Name
| LXi REIT plc | ||||||
b)
| LEI
| 2138008YZGXOKAXQVI45 | ||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares 1 pence each | ||||||
|
|
| ||||||
Identification code |
| |||||||
|
| |||||||
b)
| Nature of the transaction
| Purchase | ||||||
c)
| Price(s) and volume(s) |
|
|
|
| |||
|
|
| Price(s) | Volume(s) |
| |||
|
| 134.2p per share | 42,814 |
| ||||
|
|
|
|
| ||||
d)
| Aggregated information |
| ||||||
|
|
| ||||||
- Aggregated volume | 42,814 | |||||||
|
| |||||||
- Price | Total price £5,745,638.8 | |||||||
|
| |||||||
e)
| Date of the transaction
| 23 January 2020 | ||||||
f)
| Place of the transaction
| Outside of trading venue | ||||||
END
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.